花园生物(300401.SZ)：子公司产品中选第十一批全国药品集中采购

Core Viewpoint - Garden Biologics' subsidiary, Zhejiang Garden Pharmaceutical Co., Ltd., has been selected in the 11th batch of national centralized drug procurement, which is expected to enhance market penetration and brand influence for the company's Alendronate Sodium Tablets [1] Group 1 - The national centralized procurement results were announced on November 7, indicating that Garden Pharmaceutical's Alendronate Sodium Tablets have been selected [1] - The selection is anticipated to facilitate rapid market expansion and increase market share for the product [1] - This development is expected to promote the growth of the company's pharmaceutical formulation business and enrich its product pipeline [1]